RecruitingNot ApplicableNCT07550140
ETASCAN Project: ETAS Project 2
The Impact of Chronic Consumption of ETAS® for 12 Weeks on Cognitive, Affective, and Neural Outcomes: A Randomised Parallel Group Placebo-controlled Study
Sponsor
University of Reading
Enrollment
60 participants
Start Date
May 5, 2026
Study Type
INTERVENTIONAL
Conditions
Summary
This study aims to investigate the chronic effects of ETAS® on cognitive, affective and neural outcomes in healthy adults aged 60-80 years with mild to moderate subjective cognitive complaints.
Eligibility
Min Age: 60 YearsMax Age: 80 Years
Inclusion Criteria4
- Aging between 60-80 years old
- Having normal vision and hearing
- Having a body mass index between 18.5 and 30
- Having mild to moderate subjective cognitive complaints
Exclusion Criteria26
- Smoking
- Having food allergies
- Following restrictive and/or unbalanced diets (Appendix 6: Are you vegetarian or vegan? Yes / No; Are you currently on a weight-reducing or other special diet? Yes/No If 'Yes', please give details.)
- Being diagnosed with any psychiatric or neurologic conditions (e.g. schizophrenia, depression, dementia) including eating disorders
- Being diagnosed with any cardiometabolic diseases (including type II diabetes and cardiovascular disease), or hypertension or thrombosis related disorders or suffer from thyroid disease
- Currently taking anticoagulants, antiplatelet medication, antidepressants, proton-pump inhibitors
- Currently consuming prebiotic or probiotic supplements
- Continuous antibiotic use for > 3 days within 1 month prior to enrolment
- Continuous use of weight-loss drug for > 1 month before screening
- Having a significant gastrointestinal (GI) condition affecting absorption including (but not limited to) inflammatory bowel disease; total colectomy or bariatric surgery; irritable bowel disease; end stage renal disease; active cancer, or treatment for any cancer, in last 3 years
- History of claustrophobia
- Fitted with a pacemaker or artificial heart valve
- Have active implants, such as cochlear, ocular, or penile implant
- Experience of metal fragments e.g. shrapnel in your eyes or any other part of your body
- Drug infusion pump installed
- Have any surgically implanted metal in any part of your body, other than dental fillings and crowns (e.g. joint replacement or bone re-construction)
- Have had any surgery that might have involved metal implants
- Current or historical experience of epilepsy
- Have stimulators for nerves, brain or bone installed
- Have an intrauterine contraceptive device installed (IUD)
- Wear transdermal patches containing metal
- Wear a filling, crown, dental post (entirely within the tooth) associated with root canal treatment, retainer, bridge or braces
- For scanning, would need to remove coloured contact lenses, nail polish and makeup.
- Hearing aid wearer
- Body piercings that you cannot or will not remove for the scanning session
- Have tattoos or permanent makeup
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DIETARY_SUPPLEMENTETAS®
1500mg ETAS®
DIETARY_SUPPLEMENTPlacebo
Matched placebo capsule
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07550140
Related Trials
Brain Stimulation and Vision Testing
NCT016174081 location
Study of New Magnetic Resonance Imaging Methods of the Brain
NCT000045771 location
Top-Down Attentional Control of Visual-Processing
NCT010872811 location
Non-Invasive Monitoring Of Metabolite Levels Using Novel And Adapted MR Spectroscopy Techniques
NCT051655371 location
GUTLINK4KIDS Intervention
NCT074012121 location